Skip to Main Content

Author Details

Gaetano Zafarana
Princess Margaret Cancer Centre, University Health Network
1996
27
20
PMIDPaper TitleJournal TitlePublished Year
32391125Correction: Neoadjuvant olaparib targets hypoxia to improve radioresponse in a homologous recombination-proficient breast cancer model.Oncotarget2020
29750868BRCA Status Does Not Predict Synergism of a Carboplatin and Olaparib Combination in High-Grade Serous Ovarian Cancer Cell Lines.Mol Pharm2018
29152107Neoadjuvant olaparib targets hypoxia to improve radioresponse in a homologous recombination-proficient breast cancer model.Oncotarget2017
26876200Radiotherapy-induced miR-223 prevents relapse of breast cancer by targeting the EGF pathway.Oncogene2016
26005866Spatial genomic heterogeneity within localized, multifocal prostate cancer.Nat Genet2015
26277432In vivo studies of the PARP inhibitor, AZD-2281, in combination with fractionated radiotherapy: An exploration of the therapeutic ratio.Radiother Oncol2015
25361396Hypoxia and cellular localization influence the radiosensitizing effect of gold nanoparticles (AuNPs) in breast cancer cells.Radiat Res2014
25415046NBN gain is predictive for adverse outcome following image-guided radiotherapy for localized prostate cancer.Oncotarget2014
25456371Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study.Lancet Oncol2014
236409764FISH-IF, a four-color dual-gene FISH combined with p63 immunofluorescence to evaluate NKX3.1 and MYC status in prostate cancer.J Histochem Cytochem2013
22048240NKX3.1 haploinsufficiency is prognostic for prostate cancer relapse following surgery or image-guided radiotherapy.Clin Cancer Res2012
23041623Protease nexin 1 inhibits hedgehog signaling in prostate adenocarcinoma.J Clin Invest2012
22213075Allelic loss of the loci containing the androgen synthesis gene, StAR, is prognostic for relapse in intermediate-risk prostate cancer.Prostate2012
20235236The role of SMAD4 in human embryonic stem cell self-renewal and stem cell fate.Stem Cells2010
20590366Array CGH as a potential predictor of radiocurability in intermediate risk prostate cancer.Acta Oncol2010
20619004Tumor senescence and radioresistant tumor-initiating cells (TICs): let sleeping dogs lie!Breast Cancer Res2010
19350677Specific knockdown of OCT4 in human embryonic stem cells by inducible short hairpin RNA interference.Stem Cells2009
15489896Defining minimum genomic regions of imbalance involved in testicular germ cell tumors of adolescents and adults through genome wide microarray analysis of cDNA clones.Oncogene2004
12752258Role of gain of 12p in germ cell tumour development.APMIS2003
12941700HS5 of the human beta-globin locus control region: a developmental stage-specific border in erythroid cells.EMBO J2003
1457683312p-amplicon structure analysis in testicular germ cell tumors of adolescents and adults by array CGH.Oncogene2003
12660824Expression profile of genes from 12p in testicular germ cell tumors of adolescents and adults associated with i(12p) and amplification at 12p11.2-p12.1.Oncogene2003
11912161Coamplification of DAD-R, SOX5, and EKI1 in human testicular seminomas, with specific overexpression of DAD-R, correlates with reduced levels of apoptosis and earlier clinical manifestation.Cancer Res2002
11060036Erythroid overexpression of C/EBPgamma in transgenic mice affects gamma-globin expression and fetal liver erythropoiesis.EMBO J2000
11021820Restricted 12p amplification and RAS mutation in human germ cell tumors of the adult testis.Am J Pathol2000
8756670Rat embryo fibroblasts immortalized with simian virus 40 large T antigen undergo senescence upon its inactivation.Mol Cell Biol1996
9012519The human beta-globin locus control region confers an early embryonic erythroid-specific expression pattern to a basic promoter driving the bacterial lacZ gene.Development1996
  • 1 - 27 of 27

Recommended Authors

University of California San Francisco.
Career Start Year 2007
Number of shared co-authors 1
Center for Cancer Research, National Cancer Institute
Career Start Year 2005
Number of shared co-authors 0
Biomedicine Discovery Institute, Monash University
Career Start Year 2005
Number of shared co-authors 2
University of California los angeles
Career Start Year 2003
Number of shared co-authors 1
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 0
National Cancer Institute, National Institutes of Health
Career Start Year 2002
Number of shared co-authors 0
Meyer Cancer Center
Career Start Year 2001
Number of shared co-authors 1
Johns Hopkins University School of Medicine
Career Start Year 1999
Number of shared co-authors 3
The First Affiliated Hospital of Guangxi Medical University
Career Start Year 1998
Number of shared co-authors 1
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1997
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1997
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1997
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 0
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 1996
Number of shared co-authors 7
The University of MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 0
University of Michigan Medical School.
Career Start Year 1993
Number of shared co-authors 14
University of British Columbia
Career Start Year 1993
Number of shared co-authors 10
12224University of California san francisco
Career Start Year 1993
Number of shared co-authors 0
The Institute of Cancer Research
Career Start Year 1990
Number of shared co-authors 6
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 1
Stanford University School of Medicine
Career Start Year 1987
Number of shared co-authors 0
German Cancer Research Center (DKFZ)
Career Start Year 1986
Number of shared co-authors 6
Karolinska Institute
Career Start Year 1984
Number of shared co-authors 5
McDermott Center for Human Growth and Development.
Career Start Year 1984
Number of shared co-authors 1
Peter MacCallum Cancer Centre
Career Start Year 1983
Number of shared co-authors 3
UCSF Helen Diller Family Comprehensive Cancer Center
Career Start Year 1982
Number of shared co-authors 7
USA The Jackson Laboratory Cancer Center
Career Start Year 1982
Number of shared co-authors 2
Baylor College of Medicine
Career Start Year 1982
Number of shared co-authors 1
Oregon Health and Science University
Career Start Year 1974
Number of shared co-authors 2
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1970
Number of shared co-authors 3

Collaborators

University of Toronto
Co-authored papers 14
University Health Network, University of Toronto
Co-authored papers 7
St. Michael's Hospital, University of Toronto
Co-authored papers 7
Miller School of Medicine, University of Miami, Sylvester Comprehensive Cancer Center
Co-authored papers 5
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 5
British Columbia Cancer Research Institute
Co-authored papers 5
Schroeder Arthritis Institute
Co-authored papers 5
University of British Columbia
Co-authored papers 5
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 4
Norwich Medical School, University of East Anglia
Co-authored papers 4
University Health Network
Co-authored papers 4
Tufts University School of Medicine
Co-authored papers 3
Memorial University
Co-authored papers 3
Norwich Medical School, University of East Anglia
Co-authored papers 3
University of Pennsylvania
Co-authored papers 3
BC Cancer Research Centre
Co-authored papers 3
University of California los angeles
Co-authored papers 3
University of Toronto, Princess Margaret Cancer Centre
Co-authored papers 3
Ontario Institute for Cancer Research
Co-authored papers 3
Institut du cancer de Montreal
Co-authored papers 2
Big Data Institute, University of Oxford
Co-authored papers 2
Ontario Institute for Cancer Research
Co-authored papers 2
University of British Columbia
Co-authored papers 2
University of Sao Paulo
Co-authored papers 2
University of Miami Miller School of Medicine
Co-authored papers 2
The Institute of Cancer Research
Co-authored papers 2
University of British Columbia
Co-authored papers 2
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 2
University of Oxford, John Radcliffe Hospital
Co-authored papers 2
Oncode Institute, Netherlands Cancer Institute
Co-authored papers 2